Previous Article | Next Article ![]()
Journal of Virology, January 2001, p. 850-856, Vol. 75, No. 2
Department of Microbiology, Graduate Program
in Molecular and Cellular Biology, Arizona State University, Tempe,
Arizona 85287-2701
Received 16 August 2000/Accepted 10 October 2000
The vaccinia virus (VV) E3L gene is responsible for providing
interferon (IFN) resistance and a broad host range to VV in cell
culture. The E3L gene product contains two distinct domains. A
conserved carboxy-terminal domain, which is required for the IFN
resistance and broad host range of the virus, has been shown to bind
double-stranded RNA (dsRNA) and inhibit the antiviral dsRNA-dependent
protein kinase, PKR. The amino-terminal domain, while conserved among
orthopoxviruses, is dispensable in cell culture. To study the role of
E3L in whole-animal infections, WR strain VV recombinants either
lacking E3L (VV
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.2.850-856.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Both Carboxy- and Amino-Terminal Domains of the
Vaccinia Virus Interferon Resistance Gene, E3L, Are Required for
Pathogenesis in a Mouse Model
E3L) or expressing an amino-terminal (VVE3L
83N) or
carboxy-terminal (VVE3L
26C) truncation of E3L were constructed.
Whereas wild-type VV had a 50% lethal dose of approximately
104 PFU after intranasal infection, and elicited severe
weight loss and morbidity, VV
E3L was apathogenic, leading to no
death, weight loss, or morbidity. VV
E3L was also apathogenic after
intracranial injection. Although the amino-terminal domain of E3L is
dispensable for infection of cells in culture, both the amino- and
carboxy-terminal domains of E3L were required for full pathogenesis in
intranasal infections. These results demonstrate that the entire E3L
gene is required for pathogenesis in the mouse model.
*
Corresponding author. Mailing address: Department of
Microbiology, Graduate Program in Molecular and Cellular Biology,
Arizona State University, Tempe, AZ 85287-2701. Phone: (480) 965-1457. Fax: (480) 965-0098. E-mail: bjacobs{at}asu.edu.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|